Menu
Back to User profile » Dr Maria Palmisano
Papers published by Dr Maria Palmisano:
Pharmacokinetic Disposition Difference Between Cyclosporine and Voclosporin Drives Their Distinct Efficacy and Safety Profiles in Clinical Studies
Li Y, Palmisano M, Sun D, Zhou S
Clinical Pharmacology: Advances and Applications 2020, 12:83-96
Published Date: 1 July 2020
Modeling and simulation of the endogenous CYP3A induction marker 4β-hydroxycholesterol during enasidenib treatment
Li Y, Connarn JN, Chen J, Tong Z, Palmisano M, Zhou S
Clinical Pharmacology: Advances and Applications 2019, 11:39-50
Published Date: 15 February 2019
A Phase I, open-label, randomized, crossover study in healthy subjects to evaluate the bioavailability of, and the food effect on, a pomalidomide oral liquid suspension
Li Y, Liu L, Huang L, Wang X, Hoffmann M, Reyes J, Palmisano M, Zhou S
Clinical Pharmacology: Advances and Applications 2018, 10:89-99
Published Date: 19 July 2018
Distribution of pomalidomide into semen of healthy male subjects after multiple doses
Li Y, Wang X, Liu L, Reyes J, Palmisano M, Zhou S
Clinical Pharmacology: Advances and Applications 2018, 10:53-62
Published Date: 7 May 2018
Population pharmacokinetics of pomalidomide in patients with relapsed or refractory multiple myeloma with various degrees of impaired renal function
Li Y, Wang X, O’Mara E, Dimopoulos MA, Sonneveld P, Weisel KC, Matous J, Siegel DS, Shah JJ, Kueenburg E, Sternas L, Cavanaugh C, Zaki M, Palmisano M, Zhou S
Clinical Pharmacology: Advances and Applications 2017, 9:133-145
Published Date: 8 November 2017
Exposure-response analysis to assess concentration–QTc relationship of CC-122
Li Y, Carayannopoulos LN,Thomas M, Palmisano M, Zhou S
Clinical Pharmacology: Advances and Applications 2016, 8:117-125
Published Date: 9 September 2016